Hims & Hers Health: A Comprehensive Overview
ByAinvest
Thursday, Mar 20, 2025 4:40 pm ET1min read
HCSG--
Hims & Hers Health, a pioneering telemedicine company, is set to make waves in the healthcare industry with its recent announcement of becoming publicly traded through a merger with Oaktree Acquisition Corp [1]. This development comes as no surprise, given the company's remarkable growth and success in modernizing digital, consumer-focused healthcare services.
With a focus on men's health and wellness, Hims & Hers offers a diverse range of products and services. These include prescription medications, over-the-counter supplements, and telehealth consultations across various specialties, such as primary care, mental health, sexual health, and dermatology [1]. The company's proprietary platform connects consumers to licensed healthcare professionals, enabling greater access to high-quality, convenient, and affordable care in all 50 states.
Since its inception in 2017, Hims & Hers has facilitated over two million telehealth consultations, showcasing its commitment to improving healthcare accessibility. The company boasts impressive financial growth, with compounded annual revenue growth of over 100% in the last two years and gross margins that have more than doubled to 70%+ [1]. Moreover, over 90% of Hims & Hers' revenue is recurring in nature.
The merger with Oaktree Acquisition Corp is expected to provide further investment opportunities for Hims & Hers to expand its product offerings and accelerate its plan to become the digital front door to the healthcare system [1]. With top-tier investors, including Franklin Templeton and clients of Oaktree, backing the company, Hims & Hers is poised for continued success in the rapidly evolving healthcare landscape.
References:
[1] Hims & Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp. (2020, October 1). BusinessWire. https://www.businesswire.com/news/home/20201001005165/en/
HIMS--
OACC--
Hims & Hers Health is a telemedicine company that offers health and wellness products, including ED pills. It has been described as an ED pill company and a health and wellness provider. Hims offers a range of products, including prescription medications and over-the-counter supplements, aimed at improving men's health and wellness.
Title: Hims & Hers Health: Revolutionizing Men's Health and TelemedicineHims & Hers Health, a pioneering telemedicine company, is set to make waves in the healthcare industry with its recent announcement of becoming publicly traded through a merger with Oaktree Acquisition Corp [1]. This development comes as no surprise, given the company's remarkable growth and success in modernizing digital, consumer-focused healthcare services.
With a focus on men's health and wellness, Hims & Hers offers a diverse range of products and services. These include prescription medications, over-the-counter supplements, and telehealth consultations across various specialties, such as primary care, mental health, sexual health, and dermatology [1]. The company's proprietary platform connects consumers to licensed healthcare professionals, enabling greater access to high-quality, convenient, and affordable care in all 50 states.
Since its inception in 2017, Hims & Hers has facilitated over two million telehealth consultations, showcasing its commitment to improving healthcare accessibility. The company boasts impressive financial growth, with compounded annual revenue growth of over 100% in the last two years and gross margins that have more than doubled to 70%+ [1]. Moreover, over 90% of Hims & Hers' revenue is recurring in nature.
The merger with Oaktree Acquisition Corp is expected to provide further investment opportunities for Hims & Hers to expand its product offerings and accelerate its plan to become the digital front door to the healthcare system [1]. With top-tier investors, including Franklin Templeton and clients of Oaktree, backing the company, Hims & Hers is poised for continued success in the rapidly evolving healthcare landscape.
References:
[1] Hims & Hers, a Multi-Specialty Telehealth Platform, to Become Publicly-Traded via Merger with Oaktree Acquisition Corp. (2020, October 1). BusinessWire. https://www.businesswire.com/news/home/20201001005165/en/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet